NEW YORK (GenomeWeb News) – The US President's Emergency Plan for AIDS Relief (PEPFAR) this week announced an additional $11 million to provide Cepheid's Xpert MTB/RIF molecular diagnostic platforms and test cartridges for tuberculosis detection in 14 high-burden countries.

The funding will go toward the provision of 150 Xpert MTB/RIF instruments and 450,000 test cartridges in countries in sub-Saharan Africa and in Burma.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

The University of Southern California lodges a cross-complaint in its legal dispute with the University of California, San Diego, over a large Alzheimer's disease project.

In PNAS this week: transcript patterns in drug-resistant cancer cells, function of high-altitude adaption gene, and more.

Monitoring gene expression changes could help sniff out athletes using performance-enhancing drugs, New Scientist says.

In PLOS this week: gene fusion in premature ovarian failure, population patterns in the Franciscana dolphin, and more.